Review highlights nanocarrier systems enhancing treatment outcomes in psoriasis, indicating a need for further study.
This review looks at new developments in the treatment of psoriasis, with an emphasis on methods based on nanotechnology. It talks about the drawbacks of conventional remedies, like UVB treatments, which can have serious adverse consequences. The potential for improving drug delivery and reducing side effects being investigated for nanocarriers, including liposomes, niosomes, and metal-based nanoparticles (such as gold and silver). The analysis also highlights the potential of different nanocarrier systems to improve psoriasis treatment outcomes by summarising their advantages and disadvantages. But there are drawbacks, such as high production costs and scaling problems, which emphasise the necessity of more study to maximise these cutting-edge therapeutic approaches.
No takes yet. Share an insight, caveat, or question.
Aman Singh Patel*1, Asmit Sinha2, Ekrar Ali3, Vikash Saini3 (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: